Healthcare -
Biotechnology - NASDAQ - US
$ 0.52
-5.28 %
$ 2.46 M
Market Cap
-0.11
P/E
PCSA - OPERATING INCOME
Operating Income PCSA - Processa Pharmaceuticals, Inc.
-11.5 M
LAST VALUE
2.83%
2 YEAR CAGR
-20.42%
5 YEAR CAGR
-14.49%
10 YEAR CAGR